IBDEI15O ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20663,0)
 ;;=J0780^^116^1246^45^^^^1
 ;;^UTILITY(U,$J,358.3,20663,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20663,1,1,0)
 ;;=1^J0780
 ;;^UTILITY(U,$J,358.3,20663,1,3,0)
 ;;=3^Prochlorperazine HCL Inj up to 10mg
 ;;^UTILITY(U,$J,358.3,20664,0)
 ;;=J7060^^116^1246^3^^^^1
 ;;^UTILITY(U,$J,358.3,20664,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20664,1,1,0)
 ;;=1^J7060
 ;;^UTILITY(U,$J,358.3,20664,1,3,0)
 ;;=3^5% Dextrose/Water(500ml=1U)
 ;;^UTILITY(U,$J,358.3,20665,0)
 ;;=J7042^^116^1246^2^^^^1
 ;;^UTILITY(U,$J,358.3,20665,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20665,1,1,0)
 ;;=1^J7042
 ;;^UTILITY(U,$J,358.3,20665,1,3,0)
 ;;=3^5% Dextrose/NS(500ml=1U)
 ;;^UTILITY(U,$J,358.3,20666,0)
 ;;=J2175^^116^1246^30^^^^1
 ;;^UTILITY(U,$J,358.3,20666,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20666,1,1,0)
 ;;=1^J2175
 ;;^UTILITY(U,$J,358.3,20666,1,3,0)
 ;;=3^Meperidine HCl Inj 100mg
 ;;^UTILITY(U,$J,358.3,20667,0)
 ;;=J7100^^116^1246^22^^^^1
 ;;^UTILITY(U,$J,358.3,20667,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20667,1,1,0)
 ;;=1^J7100
 ;;^UTILITY(U,$J,358.3,20667,1,3,0)
 ;;=3^Infusion Dextran 40,500ml
 ;;^UTILITY(U,$J,358.3,20668,0)
 ;;=J7110^^116^1246^23^^^^1
 ;;^UTILITY(U,$J,358.3,20668,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20668,1,1,0)
 ;;=1^J7110
 ;;^UTILITY(U,$J,358.3,20668,1,3,0)
 ;;=3^Infusion Dextran 75,500ml
 ;;^UTILITY(U,$J,358.3,20669,0)
 ;;=J3480^^116^1246^44^^^^1
 ;;^UTILITY(U,$J,358.3,20669,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20669,1,1,0)
 ;;=1^J3480
 ;;^UTILITY(U,$J,358.3,20669,1,3,0)
 ;;=3^Potassium Chloride Inj 2meq
 ;;^UTILITY(U,$J,358.3,20670,0)
 ;;=J1940^^116^1246^16^^^^1
 ;;^UTILITY(U,$J,358.3,20670,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20670,1,1,0)
 ;;=1^J1940
 ;;^UTILITY(U,$J,358.3,20670,1,3,0)
 ;;=3^Furosemide Inj 20mg
 ;;^UTILITY(U,$J,358.3,20671,0)
 ;;=J2270^^116^1246^33^^^^1
 ;;^UTILITY(U,$J,358.3,20671,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20671,1,1,0)
 ;;=1^J2270
 ;;^UTILITY(U,$J,358.3,20671,1,3,0)
 ;;=3^Morphine Sulfate Inj up to 10mg
 ;;^UTILITY(U,$J,358.3,20672,0)
 ;;=J2430^^116^1246^43^^^^1
 ;;^UTILITY(U,$J,358.3,20672,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20672,1,1,0)
 ;;=1^J2430
 ;;^UTILITY(U,$J,358.3,20672,1,3,0)
 ;;=3^Pamidronate Disodium Inj 30mg
 ;;^UTILITY(U,$J,358.3,20673,0)
 ;;=J2550^^116^1246^46^^^^1
 ;;^UTILITY(U,$J,358.3,20673,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20673,1,1,0)
 ;;=1^J2550
 ;;^UTILITY(U,$J,358.3,20673,1,3,0)
 ;;=3^Promethzine HCL Inj up to 50mg
 ;;^UTILITY(U,$J,358.3,20674,0)
 ;;=J0886^^116^1246^12^^^^1
 ;;^UTILITY(U,$J,358.3,20674,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20674,1,1,0)
 ;;=1^J0886
 ;;^UTILITY(U,$J,358.3,20674,1,3,0)
 ;;=3^Epoetin Alfa (ESRD) 1000U
 ;;^UTILITY(U,$J,358.3,20675,0)
 ;;=J0885^^116^1246^13^^^^1
 ;;^UTILITY(U,$J,358.3,20675,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20675,1,1,0)
 ;;=1^J0885
 ;;^UTILITY(U,$J,358.3,20675,1,3,0)
 ;;=3^Epoetin Alfa (Non-ESRD)1000U
 ;;^UTILITY(U,$J,358.3,20676,0)
 ;;=J2930^^116^1246^31^^^^1
 ;;^UTILITY(U,$J,358.3,20676,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20676,1,1,0)
 ;;=1^J2930
 ;;^UTILITY(U,$J,358.3,20676,1,3,0)
 ;;=3^Methylprednisolone Inj up to 125mg
 ;;^UTILITY(U,$J,358.3,20677,0)
 ;;=J2920^^116^1246^32^^^^1
 ;;^UTILITY(U,$J,358.3,20677,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,20677,1,1,0)
 ;;=1^J2920
 ;;^UTILITY(U,$J,358.3,20677,1,3,0)
 ;;=3^Methylprednisolone Inj up to 40mg
 ;;^UTILITY(U,$J,358.3,20678,0)
 ;;=J2792^^116^1246^47^^^^1
 ;;^UTILITY(U,$J,358.3,20678,1,0)
 ;;=^358.31IA^3^2
